Literature DB >> 12970431

Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy.

Michael A Poles1, Shady Barsoum, Wenjie Yu, Jian Yu, Patricia Sun, Jeanine Daly, Tian He, Saurabh Mehandru, Andrew Talal, Martin Markowitz, Arlene Hurley, David Ho, Linqi Zhang.   

Abstract

Gammadelta T cells are primarily found in the gastrointestinal mucosa and play an important role in the first line of defense against viral, bacterial, and fungal pathogens. We sought to examine the impact of human immunodeficiency virus type 1 (HIV-1) infection on mucosal as well as peripheral blood gammadelta T-cell populations. Our results demonstrate that HIV-1 infection is associated with significant expansion of Vdelta1 and contraction of Vdelta2 cell populations in both the mucosa and peripheral blood. Such changes were observed during acute HIV-1 infection and persisted throughout the chronic phase, without apparent reversion after treatment with highly active antiretroviral therapy (HAART). Despite an increase in the expression of CCR9 and CD103 mucosal homing receptors on peripheral blood gammadelta T cells in infected individuals, mucosal and peripheral blood gammadelta T cells appeared to be distinct populations, as reflected by distinct CDR3 length polymorphisms and sequences in the two compartments. Although the underlying mechanism responsible for triggering the expansion of Vdelta1 gammadelta T cells remains unknown, HIV-1 infection appears to have a dramatic impact on gammadelta T cells, which could have important implications for HIV-1 pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970431      PMCID: PMC228518          DOI: 10.1128/jvi.77.19.10456-10467.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

Review 1.  Gammadelta T cells: functional plasticity and heterogeneity.

Authors:  Simon R Carding; Paul J Egan
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

2.  ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.

Authors:  D Cosman; J Müllberg; C L Sutherland; W Chin; R Armitage; W Fanslow; M Kubin; N J Chalupny
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

3.  Vdelta1 and Vdelta2 gammadelta T cells express distinct surface markers and might be developmentally distinct lineages.

Authors:  S C De Rosa; D K Mitra; N Watanabe; L A Herzenberg; L A Herzenberg; M Roederer
Journal:  J Leukoc Biol       Date:  2001-10       Impact factor: 4.962

4.  Essential contribution of germline-encoded lysine residues in Jgamma1.2 segment to the recognition of nonpeptide antigens by human gammadelta T cells.

Authors:  F Miyagawa; Y Tanaka; S Yamashita; B Mikami; K Danno; M Uehara; N Minato
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

5.  HIV-mediated gammadelta T cell depletion is specific for Vgamma2+ cells expressing the Jgamma1.2 segment.

Authors:  Patrick J Enders; Cheng Yin; Federico Martini; Peter S Evans; Nadia Propp; Fabrizio Poccia; C David Pauza
Journal:  AIDS Res Hum Retroviruses       Date:  2003-01-01       Impact factor: 2.205

6.  Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines.

Authors:  J Olsson; M Poles; A L Spetz; J Elliott; L Hultin; J Giorgi; J Andersson; P Anton
Journal:  J Infect Dis       Date:  2000-10-23       Impact factor: 5.226

7.  Phenotypic analysis of peripheral blood gammadelta T lymphocytes and their targeting by human immunodeficiency virus type 1 in vivo.

Authors:  S Imlach; C Leen; J E Bell; P Simmonds
Journal:  Virology       Date:  2003-01-20       Impact factor: 3.616

8.  TCR gamma delta+ and CD161+ thymocytes express HIV-1 in the SCID-hu mouse, potentially contributing to immune dysfunction in HIV infection.

Authors:  Kevin B Gurney; Otto O Yang; S Brian Wilson; Christel H Uittenbogaart
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

9.  Peripheral blood cytotoxic gammadelta T lymphocytes from patients with human immunodeficiency virus type 1 infection and AIDS lyse uninfected CD4+ T cells, and their cytocidal potential correlates with viral load.

Authors:  Sardar T A K Sindhu; Rasheed Ahmad; Richard Morisset; Ali Ahmad; José Menezes
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vgamma9Vdelta2 T cells in chronically infected patients undergoing structured treatment interruption.

Authors:  Federico Martini; Fabrizio Poccia; Delia Goletti; Stefania Carrara; Donatella Vincenti; Gianpiero D'Offizi; Chiara Agrati; Giuseppe Ippolito; Vittorio Colizzi; Leopoldo Paolo Pucillo; Carla Montesano
Journal:  J Infect Dis       Date:  2002-08-16       Impact factor: 5.226

View more
  34 in total

1.  Association between peripheral γδ T-cell profile and disease progression in individuals infected with HIV-1 or HIV-2 in West Africa.

Authors:  Natalie N Zheng; M Juliana McElrath; Papa Salif Sow; Andrew Mesher; Stephen E Hawes; Joshua Stern; Geoffrey S Gottlieb; Stephen C De Rosa; Nancy B Kiviat
Journal:  J Acquir Immune Defic Syndr       Date:  2011-06-01       Impact factor: 3.731

Review 2.  Quantitative peripheral blood perturbations of γδ T cells in human disease and their clinical implications.

Authors:  Ilan Bank; Victoria Marcu-Malina
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

Review 3.  Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes.

Authors:  Mingke Yu; Michael Vajdy
Journal:  Expert Opin Biol Ther       Date:  2010-08       Impact factor: 4.388

4.  Mucosal and Systemic γδ+ T Cells Associated with Control of Simian Immunodeficiency Virus Infection.

Authors:  Iskra Tuero; David Venzon; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2016-11-04       Impact factor: 5.422

5.  Targeting γδ T cells for immunotherapy of HIV disease.

Authors:  C David Pauza; David J Riedel; Bruce L Gilliam; Robert R Redfield
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

6.  Gamma/Delta T cell mRNA levels decrease at mucosal sites and increase at lymphoid sites following an oral SIV infection of macaques.

Authors:  David A Kosub; Andre Durudas; Ginger Lehrman; Jeffrey M Milush; Christopher A Cano; Mamta K Jain; Donald L Sodora
Journal:  Curr HIV Res       Date:  2008-11       Impact factor: 1.581

7.  Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects.

Authors:  Karina I Carvalho; Solange Maeda; Luciana Marti; Jane Yamashita; Patrick A J Haslett; Esper G Kallas
Journal:  Immunology       Date:  2008-02-12       Impact factor: 7.397

8.  Inhibition of R5-tropic HIV type-1 replication in CD4⁺ natural killer T cells by γδ T lymphocytes.

Authors:  Kyoko Omi; Masumi Shimizu; Eri Watanabe; Jiro Matsumura; Chizuno Takaku; Eiji Shinya; Hidemi Takahashi
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

Review 9.  Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure.

Authors:  Shahzada Khan; Sushama Telwatte; Martin Trapecar; Steven Yukl; Shomyseh Sanjabi
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11       Impact factor: 2.205

10.  Loss of Intra-Epithelial Endocervical Gamma Delta (GD) 1 T Cells in HIV-Infected Women.

Authors:  Natasa Strbo; Maria L Alcaide; Laura Romero; Hector Bolivar; Deborah Jones; Eckhard R Podack; Margaret A Fischl
Journal:  Am J Reprod Immunol       Date:  2015-12-15       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.